The relationship between the concentration of cell-free DNA (cfDNA) and the number of proliferating/apoptotic lymphocytes in peripheral blood of premature newborns of different gestation age and full-term newborns was determined. The experiments were performed using fluorescent spectrophotometry (with Hoechst 33342), flow cytometry, and microscopy (Feulgen staining of lymphocytes). It was determined that the lymphocyte population of premature newborns may consist of 4.6% of proliferating and 22.1% apoptotic cells. For full-term newborns, the percentage was 2.5% and 2.9%, respectively. A direct correlation between the concentration of extracellular DNA and the number of proliferating lymphocytes of full-term newborns was ascertained (r = 0.400; P < 0.05). For premature newborns, the concentration of extracellular DNA correlated both with proliferating lymphocytes and apoptotic cells. The results show that premature birth causes the induction in lymphocytes of both apoptosis and proliferation that are accompanied by an increased extracellular DNA concentration in the blood of newborn babies.
Background
It is well know that cell-free DNA in plasma is a prognostic aid for oncologic, 1,2 autoimmune, 3 and other diseases [4] [5] [6] of adults. Nevertheless, only a few investigations have been carried out of the age-specific dynamics of cfDNA concentration. 7 To our knowledge, there are no detailed studies of cell-free DNA (cfDNA) in the neonatal period. We hypothesized that the concentration of plasma DNA is increased in both the age pathology of newborns (premature birth) and the adaptation derangement in the early neonatal period. This may reflect the immune system status in such neonates.
In the present study the relationship between the concentration of cfDNA and the number of proliferating/apoptotic lymphocytes in the peripheral blood of premature newborns of different gestational age was determined.
Methods
We measured cell-free DNA in the plasma of newborns (n = 277) at different gestational ages with the clinical manifestations of adaptation derangement (perinatal CNS damage [PC-NSD], intrauterine growth retardation [IGR] , fetal infection, and respiratory failure) in the early neonatal period. Every gestation group also includes newborns without painful illness. Patient data are presented in Table 1 . Plasma samples were also obtained from 26 subjects of the control group (newborn babies without disorder) with body weights from 3000-3880 g at birth.
Peripheral venous blood (1 mL) was collected into EDTA-containing tubes (Becton Dickinson, Franklin Lakes, NJ, USA) using a catheter. DNA was extracted from the plasma samples by the generally used phenol method with previously added proteinase K (Sigma-Aldrich Biochemie GmbH, Hamburg, Germany). The DNA concentration was determined using the fluorescence method with Hoechst 33342 (Sigma-Aldrich Corp., St. Louis, MO, USA).
The apoptotic and proliferating lymphocytes were revealed by propidium iodide staining using the flow cytometer FacsCalibur (Becton Dickinson, Franklin Lakes, NJ, USA). Nuclear area and metabolism of nuclear DNA parameters (the nuclear DNA contents and degree of chromatin condensation) in newborns were also investigated by scanning integrating microdensitometry with Feulgen staining of peripheral blood lymphocytes.
Statistical treatment of the data was performed using Kruskal-Wallis and MannWhitney statistical tests.
Results
We have investigated the level of cfDNA for newborns. It was shown that the cfDNA concentration in the blood plasma of both premature newborns with clinical manifestations of adaptation derangement and without painful illness is increased significantly compared to the control group (median: 20.7 ng/mL; range: 6-42 ng/mL).
The peak of plasma cfDNA concentrations in all cases of adaptation derangement was observed in the group having a gestation age of 32-34 weeks (Fig. 1) .
The peripheral blood lymphocyte population of newborns consisted of both proliferating and apoptotic cells, but for full-term newborns (control group), the percentage was only 2.5% and 2.9%, respectively. The data for premature newborns without painful illness and with clinical manifestations of adaptation derangement in the early neonatal period is shown in Figure 2 . In all instances of gestational or clinical disorder the share of apoptotic cells was increased significantly compared to the control group.
The percentage of proliferating lymphocytes was decreased in the blood of premature newborns without painful illness and increased in cases of adaptation derangement (Fig. 2) compared to the control group.
In addition to the plasma cfDNA concentrations, the peak of apoptotic and proliferating lymphocytes (in the case of painful adaptation derangement) was found to be at the gestational age of 32-34 weeks.
The relationship between the concentration of blood plasma cfDNA and the number of proliferating/apoptotic lymphocytes in the peripheral blood of premature newborns was determined. A direct correlation was found be- tween the concentration of extracellular DNA and the number of proliferating lymphocytes of full-term newborns ( Table 2 ). For premature newborns, the concentration of extracellular DNA correlated with both proliferating lymphocytes and apoptotic cells.
Discussion
Our results show that the prematurity as well as the adaptation derangement in the early neonatal period is accompanied by the abnormality of lymphocyte apoptosis in the immediate peripheral blood. In healthy newborns it may be a consequence of either the transfer from intrinsic birth hypoxia to pulmonary respiration or physiological acidosis. In this case, phagocytes eliminate the apoptotic knots without the start of the autoimmune process. The increase of the proportion of apoptotic lymphocytes in the case of adaptation derangement during the early neonatal period is associated with an increased cfDNA concentration in the blood of newborns, which could be due to an apoptotic lymphocyte origin for the high plasma cfDNA concentration. However, it is possible that the cfDNA itself may cause the apoptosis of immature lymphocytes through its activating of the induction of apoptosis. The apoptotic DNA is enriched by CpG-sequences that may provoke an autoimmune process [8] [9] [10] or phagocytic component of immune system breakdown during the neonatal period. Of interest, the peak of the plasma cfDNA concentrations in all cases of adaptation derangement (PCNSD, IGR, fetal infection, and respiratory failure) was observed in those of gestational age of 32-34 weeks. This may explain the experimental data concerning the increase of the prevalence of periventricular hemorrhage during this period.
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Proliferating lymphocytes may also be responsible for the increased cfDNA concentration in the blood plasma of newborn babies. On the one hand, activating lymphocytes may release the DNA 12, 13 ; on the other hand, apoptotic cfDNA may activate the lymphocytes. It is possible that both mechanisms may coexist and intensify one another. The issue remains open and requires further investigation.
This research does not rule out the possibility of cfDNA having its origin in other cells. 14 
Conclusion
Premature birth causes the induction of lymphocytic apoptosis and proliferation that are accompanied by an increased cfDNA concentration in the blood of newborn infants.
